Cardiomyopathy III: Hypertrophic Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy V: Interprofessional Care
Dysrhythmias V: Evaluating Dysrhythmias
Imaging Studies for Cardiovascular System I:Echocardiography
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 18, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Sunayana C Pydah1, Kimberlee Mauck, Chelsea Shultis
1At the time this article was written, Sunayana C. Pydah, Kimberlee Mauck , and Chelsea Shultis were students in the PA program at the University of Lynchburg in Lynchburg, Va. Ms. Pydah now practices in pediatrics at Santa Clara Valley Medical Center in San Jose, Calif. Ms. Mauck practices in the neurological ICU at the University of Virginia Medical Center in Charlottesville, Va., and is an adjunct professor in the PA program at the University of Lynchburg. Ms. Shultis practices in neurosurgery at Riverside Health System in Newport News, Va. At the University of Lynchburg, Jenna Rolfs is program director and an assistant professor in the PA program and practices at the Free Clinic of Central Virginia; Eric Schmidt is an associate professor in the PA program; and Joyce Nicholas is director of evaluation, assessment, and compliance and a professor in the PA program. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Hypertrophic cardiomyopathy (HCM) is a common inherited heart muscle disease affecting all ages, often presenting in adolescents and athletes. Early screening and management are crucial to prevent sudden cardiac death in undiagnosed individuals.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: